Pharmacy compounding: implications of the 2012 meningitis outbreak : hearing of the Committee on Health, Education, Labor, and Pensions, United States Senate, One Hundred Twelfth Congress, second session on examining pharmacy compounding, focusing on implications of the 2012 meningitis outbreak, November 15, 2012.

Similar Items

• The fungal meningitis outbreak : could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012
  Published: (2014)
• The fungal meningitis outbreak : could it have been prevented? : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Twelfth Congress, second session, November 14, 2012.
  Published: (2014)
• A continuing investigation into the fungal meningitis outbreak and whether it could have been prevented : hearing before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, April 16, 2013
  Published: (2015)
• Drug compounding : FDA authority and possible issues for Congress /
  by: Bodie, Agata
  Published: (2018)
• Examining drug compounding : hearing before the Subcommittee on Health of the Committee on Energy and Commerce, House of Representatives, One Hundred Thirteenth Congress, first session, May 23, 2013
  Published: (2014)